ModìLiteTM: Micro-invasive Laser Thermal Ablation (LTA) treatment for the management of Benign Thyroid Nodules (BTNs)
WEBINAR February 6, 2021
9:30-11:00 A.M., E.T.
DESCRIPTION
Nodular thyroid disease represents a frequent pathology which requires the involvement of multiple professionals for its proper care. The correct management of the patient with a Benign Thyroid Nodule (BTN) therefore requires a multidisciplinary approach, which starts from a correct diagnosis, often based on ultrasound, followed by a treatment which must be effective, as minimally invasive as possible, and proposed taking into consideration the different and multiple needs of patients. In this scenario, ultrasound-guided thermal ablation treatments are playing an increasingly important role in the multidisciplinary management of patients with benign nodular thyroid disease, and are increasingly offered as a first therapeutic option. During this webinar, ModìLite micro-invasive procedure for the percutaneous laser thermal ablation treatment of BTNs will be presented, with particular attention to the indications, the results reported in the literature and possible future applications.
ADDITIONAL & REGISTRATION INFORMATION
Johns Hopkins Seventh Annual Atlantic Otolaryngology-Head and Neck Surgery Update
Saturday, February 20, 2021
Internet Live Conference
This activity has been approved for AMA PRA Category 1 Credit ™.
DESCRIPTION
Changes in otolaryngology–head and neck surgery are occurring at a rapid pace, including advances in transoral robotic surgery, endoscopic skull base surgery, diagnosis and treatment of patients with head and neck cancer, and the assessment and treatment of hearing loss. The goal of this course is to provide health care practitioners with a comprehensive update on current practices in all fields of otolaryngology–head and neck surgery.
Registration Link: https://hopkinscme.cloud-cme.com/aph.aspx?P=5&EID=30014
Second Annual Olfactory Neuroblastoma
(Esthesioneuroblastoma) Patient Education Meeting
When: Saturday, February 27, 2021, 10 a.m. to 1 p.m.
Eastern time
Where: Virtual meeting.
WebEx meeting link:
https://nih.webex.com/nih/j.phpMTID=m3fab80d3bbd5da377c0d29798717411e
Meeting number: 126 923 4105
Password: SPjPxgUK224
Call-in number (US/Canada): 1-650-479-3208
Meeting password and call-in number are the same for
every link.
Breakout session #1
WebEx meeting link:
https://nih.webex.com/nih/j.phpMTID=m97fba9531974ae9006058fcdf438da4c
Meeting number: 126 086 3529
Breakout session #2
WebEx meeting link:
https://nih.webex.com/nih/j.phpMTID=m2d859a8bd0385cc3cb12e2c07c0e2066
Meeting number: 126 927 2020
Breakout session #3
WebEx meeting link:
https://nih.webex.com/nih/j.phpMTID=ma308c587f6db110ccc94de6def9a7edb
Meeting number: 126 799 7332
Breakout session #4
WebEx meeting link:
https://nih.webex.com/nih/j.phpMTID=m0fe9035331290db88d1e454c216e15b0
Meeting number: 126 009 1335
Who: Presenters will include people personally affected by olfactory neuroblastoma, and medical and
scientific experts from the National Institute on Deafness and Other Communication Disorders (NIDCD),
the National Cancer Institute (NCI), Johns Hopkins, and other major hospital centers throughout the
United States.
What:
• Perspectives from patients and family members affected by olfactory neuroblastoma.
• Information on advances in surgery, radiation, and other treatments.
• Research updates on genomics, outcomes, and clinical studies.
• Information about clinical trials.
This meeting is directed by Nyall R. London, Jr., M.D., Ph.D.; Gary Gallia, M.D., Ph.D.; and Murray
Ramanathan, M.D.; and is sponsored by the NIDCD.
Please direct any questions or reasonable accommodation requests to Dr. London, principal investigator
of the NIDCD Sinonasal and Skull Base Tumor Program
(https://www.nidcd.nih.gov/research/labs/sinonasal-and-skull-base-tumor-program),
at nyall.london@nih.gov or 301-402-4216.
AHNS Members may submit related meetings of interest to the AHNS office.